The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Somatropin (r-DNA) for injection (Brand name: Genotropin)
- Manufactured by
FDA-approved indication: Long-term treatment of pediatric patients who have growth failure due to Prader-Willi syndrome (PWS). (Genotropin is not appropriated for all children with PWS, so please talk to your doctor.)
National Library of Medicine Drug Information Portal